Importantly, while prior studies applied RhoA inhibitors before infection, our model treated cells post-infection (at 48 hpi), yet still observed significant antiviral effects, reinforcing the relevance of RhoA as a conserved target across Orthoflavivirus. The gene discussed is RHOA; the disease is infection.